英国《金融时报》对处方数据进行的分析显示，美国儿童肥胖人数急剧上升，导致使用治疗二型糖尿病及与糖尿病有关病症药物的人数显著增加。 Soaring obesity in US children is creating a dramatic increase in the number taking medicines for type-II diabetes and those with diabetes-related conditions, according to a Financial Times analysis of prescription data.
这项分析报告由美国最大的药品福利管理服务商Medco为英国《金融时报》提供。该分析发现，2001至2005年间，使用治疗二型糖尿病药物的儿童数量增长逾一倍。 The analysis, for the FT by Medco, the largest US drug benefits manager, found the number of children taking medicine for type-II diabetes more than doubled between 2001 and 2005.
此外，还发现在使用治疗二型糖尿病药物的儿童中，有很大比例的人还使用其它药物，这些药物用于治疗高血压、高胆固醇、哮喘和关节疼痛等通常与肥胖和糖尿病相关的严重成人慢性疾病。 In addition, an alarming percentage of children taking type-II diabetes drugs were found to be taking drugs for serious adult-like chronic conditions often related to obesity and diabetes such as hypertension, high cholesterol, asthma and joint pain.